I agree that this site is using cookies. You can find further informations here.
X
Matsumoto, Yoshie
248  results:
Search for persons X
?
1

Epstein–Barr virus‐positive monoclonal lymphoplasmacytic pr..:

Hibiya, Takashi ; Nagahama, Kiyotaka ; Matsumoto, Yoshie...
Neuropathology.  44 (2023)  2 - p. 104-108 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Proselfs depend more on model-based than model-free learnin..:

Oguchi, Mineki ; Li, Yang ; Matsumoto, Yoshie...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

The neuroanatomy of social trust predicts depression vulner..:

Fermin, Alan S. R. ; Kiyonari, Toko ; Matsumoto, Yoshie...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
4

ML-7 Liquid biopsy for MYD88 mutation in cerebrospinal flui..:

Yuki, Yamagishi ; Sasaki, Nobuyoshi ; Matsushita, Yuko...
Neuro-Oncology Advances.  3 (2021)  Supplement_6 - p. vi23-vi23 , 2021
Link: https://doi.org/10.1093/..
 
?
5

CTNI-65. COMBINED RITUXIMAB, METHOTREXATE, PROCARBAZINE, VI..:

Nagane, Motoo ; Sasaki, Nobuyoshi ; Kobayashi, Keiichi...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii57-ii57 , 2020
Link: https://doi.org/10.1093/..
 
?
6

ML-02 Chemotherapy for patients with relapsed or refractory..:

Nagane, Motoo ; Sasaki, Nobuyoshi ; Kobayashi, Keiichi...
Neuro-Oncology Advances.  2 (2020)  Supplement_3 - p. ii15-ii15 , 2020
Link: https://doi.org/10.1093/..
 
?
7

ML-21 Tirabrutinib monotherapy for relapsed/refractory prim..:

Kobayashi, Keiichi ; Sasaki, Nobuyoshi ; Saito, Kuniaki...
Neuro-Oncology Advances.  2 (2020)  Supplement_3 - p. ii18-ii18 , 2020
Link: https://doi.org/10.1093/..
 
?
8

STMO-18 SUBPIAL RESECTION OF GLIOMA USING CUSA CLARITY:

Nagane, Motoo ; Shiokawa, Yoshiaki ; Shimada, Daisuke...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii20-ii21 , 2019
Link: https://doi.org/10.1093/..
 
?
9

BT-09 CLINICAL AND MOLECULAR GENETIC FEATURE OF CEREBELLAR ..:

Nagane, Motoo ; Shiokawa, Yoshiaki ; Matsumoto, Yoshie...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii37-ii38 , 2019
Link: https://doi.org/10.1093/..
 
?
10

NI-23 ULTRA-HIGH-RESOLUTION CT ANGIOGRAPHY FOR BRAIN TUMOR ..:

Nagane, Motoo ; Shiokawa, Yoshiaki ; Gomyo, Miho...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii29-ii30 , 2019
Link: https://doi.org/10.1093/..
 
?
11

ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS ..:

Shiokawa, Yoshiaki ; Takayama, Nobuyuki ; Yamagishi, Yuki...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii32-ii32 , 2019
Link: https://doi.org/10.1093/..
 
?
12

COT-13 THE USEFULNESS OF THE CEREBRAL ANGIOGRAPHY FOR RESEC..:

Nagane, Motoo ; Shiokawa, Yoshiaki ; Noguchi, Akio...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii42-ii42 , 2019
Link: https://doi.org/10.1093/..
 
?
13

COT-19 TREATMENT EXPERIENCE OF AND TIPS FOR ADMINISTRATING ..:

Nagane, Motoo ; Shiokawa, Yoshiaki ; Matsumoto, Yoshie...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii44-ii44 , 2019
Link: https://doi.org/10.1093/..
 
?
14

NQPC-06 FUNCTIONAL OUTCOMES OF INITIAL TREATMENTS FOR PATIE..:

Okajima, Yasutomo ; Nagane, Motoo ; Shiokawa, Yoshiaki...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii30-ii30 , 2019
Link: https://doi.org/10.1093/..
 
?
15

COT-20 PERIOPERATIVE STATUS OF SERUM D-DIMER LEVEL AND VENO..:

Nagane, Motoo ; Shiokawa, Yoshiaki ; Iijima, Shohei...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii44-ii44 , 2019
Link: https://doi.org/10.1093/..
 
1-15